» Articles » PMID: 20585626

Identification of a Functional Genetic Variant at 16q12.1 for Breast Cancer Risk: Results from the Asia Breast Cancer Consortium

Abstract

Genetic factors play an important role in the etiology of breast cancer. We carried out a multi-stage genome-wide association (GWA) study in over 28,000 cases and controls recruited from 12 studies conducted in Asian and European American women to identify genetic susceptibility loci for breast cancer. After analyzing 684,457 SNPs in 2,073 cases and 2,084 controls in Chinese women, we evaluated 53 SNPs for fast-track replication in an independent set of 4,425 cases and 1,915 controls of Chinese origin. Four replicated SNPs were further investigated in an independent set of 6,173 cases and 6,340 controls from seven other studies conducted in Asian women. SNP rs4784227 was consistently associated with breast cancer risk across all studies with adjusted odds ratios (95% confidence intervals) of 1.25 (1.20-1.31) per allele (P = 3.2 x 10(-25)) in the pooled analysis of samples from all Asian samples. This SNP was also associated with breast cancer risk among European Americans (per allele OR = 1.19, 95% CI = 1.09-1.31, P = 1.3 x 10(-4), 2,797 cases and 2,662 controls). SNP rs4784227 is located at 16q12.1, a region identified previously for breast cancer risk among Europeans. The association of this SNP with breast cancer risk remained highly statistically significant in Asians after adjusting for previously-reported SNPs in this region. In vitro experiments using both luciferase reporter and electrophoretic mobility shift assays demonstrated functional significance of this SNP. These results provide strong evidence implicating rs4784227 as a functional causal variant for breast cancer in the locus 16q12.1 and demonstrate the utility of conducting genetic association studies in populations with different genetic architectures.

Citing Articles

Towards functional maps of non-coding variants in cancer.

Wang Y, Hon G Front Genome Ed. 2024; 6:1481443.

PMID: 39544254 PMC: 11560456. DOI: 10.3389/fgeed.2024.1481443.


Iroquois homeobox 4 (IRX4) derived micropeptide promotes prostate cancer progression and chemoresistance through Wnt signalling dysregulation.

Fernando A, Liyanage C, Srinivasan S, Panchadsaram J, Rothnagel J, Clements J Commun Med (Lond). 2024; 4(1):224.

PMID: 39487222 PMC: 11530646. DOI: 10.1038/s43856-024-00613-9.


Refining the genetic risk of breast cancer with rare haplotypes and pattern mining.

Letsou W, Wang F, Moon W, Im C, Sapkota Y, Robison L Life Sci Alliance. 2023; 6(10).

PMID: 37541849 PMC: 10403637. DOI: 10.26508/lsa.202302183.


Comparisons of clinical characteristics, prognosis, epidemiological factors, and genetic susceptibility between HER2-low and HER2-zero breast cancer among Chinese females.

Zheng L, Zhang Y, Wang Z, Wang H, Hao C, Li C Cancer Med. 2023; 12(14):14937-14948.

PMID: 37387469 PMC: 10417066. DOI: 10.1002/cam4.6129.


Association between the CASC16 rs4784227 polymorphism and breast cancer risk and prognosis in a northeast Chinese Han population.

Zhang Y, Kou C, Jia L, Gao Y, Li X, Wu H PeerJ. 2022; 10:e14462.

PMID: 36540803 PMC: 9760016. DOI: 10.7717/peerj.14462.


References
1.
Wang Y, Hu Z, Liang J, Wang Z, Tang J, Wang S . A tandem repeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women. Carcinogenesis. 2008; 29(6):1197-201. DOI: 10.1093/carcin/bgn099. View

2.
Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J . Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A. 2008; 105(11):4340-5. PMC: 2393811. DOI: 10.1073/pnas.0800441105. View

3.
Ding S, Yu J, Chen S, Hsu G, Kuo S, Lin Y . Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis. 2008; 30(1):43-9. DOI: 10.1093/carcin/bgn233. View

4.
Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q . Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. Breast Cancer Res Treat. 2008; 114(2):327-38. DOI: 10.1007/s10549-008-9998-0. View

5.
Chan K, Liu W, Long J, Yip S, Chan S, Shu X . Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women. J Med Genet. 2008; 46(1):32-9. PMC: 2782922. DOI: 10.1136/jmg.2007.057174. View